Liisa Hurme

President and CEO of Orion Corporation, Chairman of the Executive Management Board as of 1 November 2022

Ownership of shares 31 Dec 2023:  30,020 Orion Corporation B shares

Career in Orion

2022- President and CEO, Orion Corporation
2019-2022 Senior Vice President, Global Operations
2014-2022 Chairman of the Board of Fermion Oy
2014-2018 Senior Vice President, Specialty Products
2008-2013 Senior Vice President, Proprietary Products
2005-2007 Head of Urology and Oncology business
2004-2005 Program Leader of pharmaceutical development projects for Hormonal and Urological therapies
2002-2004 Portfolio Manager
2001-2002 Project Manager
1999-2001 Researcher and Project Manager, Hormonal therapies

Earlier career

1995-1999 Senior Research Associate, Pharmacia & Upjohn, Diagnostics (Sweden) and ELIAS GmbH (Germany) and Institute Pasteur (France)

Current key positions of trust

Chairman of the Board of the Chemical Industry Federation of Finland 2025-2026

Former key positions of trust

Member of the Board: PharmaService Oy 2014-2016, Finnish Bioindustries FIB 2010-2016
Member of the Economic & Social Policy Committee of the European Federation of Pharmaceutical Industries and Associations (EFPIA) 2010-2015, Member of the Healthcare Sector Committee of the National Emergency Supply Organisation, NESO, 2014-2015

Liisa Hurme completed her doctoral thesis on biochemistry at the University of Helsinki, Faculty of Science, in 1996.